Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Interventional × Hyperthermia × Clear all

Phase

Phase NA 27 Phase 3 10 Phase 2 10 Phase 1 6 Phase 2/3 2 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 599 Breast Neoplasms 533 Neoplasms 498 Leukemia, Myeloid, Acute 410 Colorectal Neoplasms 378 Multiple Myeloma 369 Melanoma 359 Prostatic Neoplasms 317 Neoplasm Metastasis 309 Pancreatic Neoplasms 307 Lymphoma 288 Recurrence 281 Ovarian Neoplasms 279 Lung Neoplasms 253 Leukemia 249 Lymphoma, Non-Hodgkin 246 Glioblastoma 236 Precursor Cell Lymphoblastic Leukemia-Lymphoma 214 Stomach Neoplasms 210 Leukemia, Lymphocytic, Chronic, B-Cell 198 Carcinoma, Hepatocellular 196 Squamous Cell Carcinoma of Head and Neck 181 Myelodysplastic Syndromes 180 Lymphoma, Large B-Cell, Diffuse 179 Carcinoma, Renal Cell 173 Brain Neoplasms 151 Lymphoma, Follicular 148 Head and Neck Neoplasms 141 Triple Negative Breast Neoplasms 137 Lymphoma, Mantle-Cell 135

Interventions

tislelizumab 1 spartalizumab 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022692 2023-09-05

HEAIS001

Zhejiang Hospital

Phase 1/2 Completed

Gastrointestinal

Hyperthermia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡